SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001013594-13-000471
Filing Date
2013-09-03
Accepted
2013-09-03 17:07:04
Documents
4

Document Format Files

Seq Description Document Type Size
1 AUGUST 30, 2013 echo13da-083013.htm SC 13D/A 240558
2 logo3.jpg GRAPHIC 62015
3 logoline.jpg GRAPHIC 27666
4 signature.jpg GRAPHIC 27653
  Complete submission text file 0001013594-13-000471.txt   404455
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Subject) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52931 | Film No.: 131075657
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019 212-581-0500
Platinum Partners Value Arbitrage Fund, LP (Filed by) CIK: 0001299265 (see all company filings)

IRS No.: 141861954 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A